Top Biomed Stock Signal: ADIL
Report Date: 12-18-2023
Symbol: ADIL - Adial Pharmaceuticals, Inc.
Sector:
Industry:
Top Biomed Stock Signal: ADIL
Adial Pharmaceuticals, Inc. (ADIL)
1180 Seminole Trl Ste 495
Charlottesville, VIRGINIA 22901
Phone: 14344229800
Website: https://www.adialpharma.com
CEO: Mr. William Stilley
NASDAQ, Nasdaq Capital Market
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Charlottesville, Virginia.